Machine Learning of the Whole Genome Sequence of Mycobacterium tuberculosis : A Scoping PRISMA-Based Review.
Ricardo Perea-JacoboGuillermo René Paredes-GutiérrezMiguel Ángel Guerrero-ChevannierDora-Luz FloresRaquel Muñiz-SalazarPublished in: Microorganisms (2023)
Tuberculosis (TB) remains one of the most significant global health problems, posing a significant challenge to public health systems worldwide. However, diagnosing drug-resistant tuberculosis (DR-TB) has become increasingly challenging due to the rising number of multidrug-resistant (MDR-TB) cases, despite the development of new TB diagnostic tools. Even the World Health Organization-recommended methods such as Xpert MTB/XDR or Truenat are unable to detect all the Mycobacterium tuberculosis genome mutations associated with drug resistance. While Whole Genome Sequencing offers a more precise DR profile, the lack of user-friendly bioinformatics analysis applications hinders its widespread use. This review focuses on exploring various artificial intelligence models for predicting DR-TB profiles, analyzing relevant English-language articles using the PRISMA methodology through the Covidence platform. Our findings indicate that an Artificial Neural Network is the most commonly employed method, with non-statistical dimensionality reduction techniques preferred over traditional statistical approaches such as Principal Component Analysis or t-distributed Stochastic Neighbor Embedding.
Keyphrases
- mycobacterium tuberculosis
- drug resistant
- multidrug resistant
- artificial intelligence
- machine learning
- pulmonary tuberculosis
- acinetobacter baumannii
- neural network
- global health
- gram negative
- big data
- mental health
- editorial comment
- deep learning
- healthcare
- bioinformatics analysis
- public health
- escherichia coli
- gene expression
- systematic review
- human immunodeficiency virus
- pseudomonas aeruginosa
- genome wide
- dna methylation
- adverse drug